Global Development Medical Director, Hematology Oncology

AstraZeneca • Boston, MA

1d • $241,613 - $362,420 • Hybrid

About The Position

AstraZeneca is a global, science-led, patient-focused biopharmaceutical company dedicated to the discovery, development, and commercialization of prescription medicines for serious diseases. Within Hematology R&D, the company is committed to advancing science to deliver life-changing medicines for patients in need. This unit covers the value chain from discovery through late-stage development, focusing on a combination-focused pipeline across six scientific platforms to address unmet needs in hematological cancers. The Global Development Medical Director is a key member of the Clinical Project Team (CPT) and Global Study Team (GST), collaborating cross-functionally in a matrix environment. This role provides clinical support for early and/or late phase clinical program strategies, including trial design, implementation, data review, interpretation, reporting, and activities for worldwide registration. A critical aspect of this role is the medical monitoring of clinical studies to ensure patient safety, sharing responsibility with Clinical Operations in study planning, execution, and closure. Experienced individuals may also contribute to functional process improvement initiatives and cross-asset/indication working groups.

Requirements

• MD or international equivalent is required.
• Minimum of 2 years of relevant experience.
• Medical hemato-oncology clinical training is required.
• Possesses general knowledge of Good Clinical Practice (GCP) and other regulations governing clinical research.
• Possesses general knowledge of medical monitoring.
• Possesses general knowledge of the Regulatory approval process in relevant countries.
• Possesses general knowledge of pharmaceutical industry/R&D operations.
• Possesses general knowledge of marketing and commercial fundamentals.
• Good understanding of clinical trials methodology.
• Strong communication & presentation skills to clearly communicate scientific concepts /data to leadership committees both internally or externally.

Nice To Haves

• Board Certification is preferred.
• Clinical or research experience (in an academic, pharmaceutical or CRO environment) related to the design and/or conduct of clinical studies in oncology and/or malignant hematology is preferred.

Responsibilities

• Ensuring the risk-benefit of a clinical study and that all clinical studies operate to the highest ethical and safety standards in compliance with FDA, EMEA, ICH, GCP guidelines, and AZ SOPs regarding safety.
• Working cross-functionally and leading all aspects of the design and implementation of clinical hemato-oncology projects as a leader of the Clinical Product Team (CPT) and member of the Clinical Sub-Team (CST).
• Ensuring the overall scientific and medical content of all clinical programs is scientifically and clinically rigorous.
• Contributing significantly to the development of program strategy for assigned compound(s)/programs and working with GPT/CPT members to develop a compelling business case for governance approval.
• Providing expert clinical input to influence study design through collaboration with investigators, key external experts, study sites, team members, and internal stakeholders.
• Participating or leading the review and assessment of new opportunities and ESRs.
• Accountable for the relevance and accuracy of clinical science underpinning clinical studies based on detailed scientific review and consultation.
• Providing clinical and scientific leadership and integrity for protocols and/or components of clinical plans.
• Ensuring the delivery of the final protocol and its governance approval.
• Providing expert input into/leading the development of the protocol and related documents and the development and delivery of the clinical study report.
• Having full responsibility for the planning, implementation, and daily operation of assigned drug development projects in hemato-oncology.
• Supporting or leading interactions with global medical affairs, marketing companies, and commercial teams in collaboration with GCH/GCPL to ensure cross-functional input into protocols.
• Responding in a timely manner to investigational study sites for local ICF changes, protocol, and EC/IRB questions/requests.
• Contributing to the development and delivery of investigator and monitor training.
• Supporting the development of clinical components of regulatory and EC/IRB submission documents for marketing approval.
• Preparing clinical development plans that integrate pre-clinical and early clinical findings, ensuring cross-functional alignment throughout early development phases.
• Presenting and defending protocols and clinical development plans at internal governance forums.
• Serving as Medical Monitor, responsible for the safety monitoring of clinical trials, and as a medical expert for Phase I/II or Phase III studies, innovating the process from protocol development through individual study report and coordinated regulatory documentation.
• Preparing various official and regulatory documents for Regulatory and other agencies, such as Dossiers, BLAs, INDs, Safety and Annual reports, and handling responses to regulatory agencies regarding complex clinical development issues.
• Implementing clinical R&D policies, SOPs, and related directives.
• Contributing to and supporting Department/Clinical initiatives to improve the quality and content of all clinical programs and cross-functional/organizational processes.

Benefits

• Short-term incentive bonus opportunity
• Equity-based long-term incentive program (salaried roles)
• Retirement contribution (hourly roles)
• Commission payment eligibility (sales roles)
• Qualified retirement program [401(k) plan]
• Paid vacation and holidays
• Paid leaves
• Health benefits including medical, prescription drug, dental, and vision coverage

What This Job Offers

• Job Type: Full-time
• Career Level: Senior